BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

7254

543427

MEDPLUS

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MEDPLUS HEALTH SERV LTD performance

Today’s low

Today’s high

₹ 785.50 ₹ 822.95
₹ 806.15

52 week low

52 week high

₹ 616.00 ₹ 875.65
₹ 806.15

Open Price

₹ 816.60

Prev. Close

₹ 820.35

Volume (Shares)

141859.00

Total traded value

₹ 1143.59

Upper Circuit

₹ 984.40

Lower Circuit

₹ 656.30

info

MEDPLUS HEALTH SERV LTD Share Price Update

As of the latest trading session, MEDPLUS HEALTH SERV LTD share price is currently at ₹ 806.15, which is down by ₹ -14.19 from its previous closing. Today, the stock has fluctuated between ₹ 785.50 and ₹ 822.95. Over the past year, MEDPLUS HEALTH SERV LTD has achieved a return of 15.67 %. In the last month alone, the return has been 7.40 %. Read More...

MEDPLUS HEALTH SERV LTD fundamentals


  • Market cap (Cr)

    9,636.47

  • P/E Ratio (TTM)

    264.39

  • Beta

    0.42

  • Book Value / share

    101.08

  • Return on equity

    0.75%

  • EPS (TTM)

    3.03

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    9.37

info icon alternate text
  • Market cap (Cr)

    9,588.70

  • P/E Ratio (TTM)

    264.39

  • Beta

    0.40

  • Book Value / share

    101.08

  • Return on equity

    0.75%

  • EPS (TTM)

    3.03

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    9.37

info icon alternate text

MEDPLUS HEALTH SERV LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 176.79
Operating Expense 166.95
Net Profit 9.37
Net Profit Margin (%) 5.30
Earnings Per Share (EPS) 0.78
EBITDA 20.88
Effective Tax Rate (%) 22.11
Particulars SEP 2024 (Values in Cr)
Revenue 156.23
Operating Expense 148.84
Net Profit 7.75
Net Profit Margin (%) 4.96
Earnings Per Share (EPS) 0.65
EBITDA 19.20
Effective Tax Rate (%) 19.60
Particulars JUN 2024 (Values in Cr)
Revenue 178.33
Operating Expense 168.59
Net Profit 9.24
Net Profit Margin (%) 5.18
Earnings Per Share (EPS) 0.77
EBITDA 20.16
Effective Tax Rate (%) 20.27
Particulars MAR 2024 (Values in Cr)
Revenue 148.37
Operating Expense 143.95
Net Profit 9.92
Net Profit Margin (%) 6.68
Earnings Per Share (EPS) 0.83
EBITDA 14.83
Effective Tax Rate (%) -56.80
Particulars DEC 2023 (Values in Cr)
Revenue 148.10
Operating Expense 145.70
Net Profit 3.17
Net Profit Margin (%) 2.14
Earnings Per Share (EPS) 0.27
EBITDA 12.59
Effective Tax Rate (%) 24.82
Particulars MAR 2024 (Values in Cr)
Revenue 467.03
Operating Expense 467.40
Net Profit 9.44
Net Profit Margin (%) 2.02
Earnings Per Share (EPS) 0.79
EBITDA 39.48
Effective Tax Rate (%) -36.02
Particulars MAR 2023 (Values in Cr)
Revenue 213.93
Operating Expense 222.58
Net Profit 5.54
Net Profit Margin (%) 2.58
Earnings Per Share (EPS) 0.46
EBITDA 29.45
Effective Tax Rate (%) 26.87
Particulars MAR 2022 (Values in Cr)
Revenue 145.71
Operating Expense 149.68
Net Profit 5.58
Net Profit Margin (%) 3.82
Earnings Per Share (EPS) 0.50
EBITDA 12.84
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 68.31
Operating Expense 78.99
Net Profit -8.57
Net Profit Margin (%) -12.54
Earnings Per Share (EPS) -0.82
EBITDA -6.68
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 61.11
Operating Expense 87.39
Net Profit -24.87
Net Profit Margin (%) -40.69
Earnings Per Share (EPS) -1282.16
EBITDA -23.25
Effective Tax Rate (%) -2.09
Particulars MAR 2024 (Values in Cr)
Book Value / Share 132.01
ROE % 4.27
ROCE % 6.74
Total Debt to Total Equity 0.62
EBITDA Margin 7.01
Particulars MAR 2023 (Values in Cr)
Book Value / Share 124.99
ROE % 3.45
ROCE % 5.57
Total Debt to Total Equity 0.59
EBITDA Margin 6.84
Particulars MAR 2022 (Values in Cr)
Book Value / Share 118.84
ROE % 8.82
ROCE % 10.26
Total Debt to Total Equity 0.65
EBITDA Margin 8.04
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8030.09
ROE % 10.03
ROCE % 12.68
Total Debt to Total Equity 0.85
EBITDA Margin 7.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share 27206.29
ROE % 0.44
ROCE % 8.68
Total Debt to Total Equity 1.11
EBITDA Margin 5.26
Particulars MAR 2024 (Values in Cr)
Book Value / Share 98.10
ROE % 0.75
ROCE % 1.13
Total Debt to Total Equity 0.08
EBITDA Margin 8.48
Particulars MAR 2023 (Values in Cr)
Book Value / Share 95.66
ROE % 0.44
ROCE % 1.07
Total Debt to Total Equity 0.06
EBITDA Margin 13.76
Particulars MAR 2022 (Values in Cr)
Book Value / Share 93.28
ROE % 0.63
ROCE % 0.90
Total Debt to Total Equity 0.03
EBITDA Margin 8.81
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3273.97
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.01
EBITDA Margin -9.78
Particulars MAR 2020 (Values in Cr)
Book Value / Share 20392.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -38.06
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 141.68
Total Assets 3004.80
Total Liabilities 3004.80
Total Equity 1577.35
Share Outstanding 119536952
Price to Book Ratio 7.03
Return on Assets (%) 2.17
Return on Capital (%) 4.15
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 283.83
Total Assets 2796.71
Total Liabilities 2796.71
Total Equity 1490.50
Share Outstanding 119305676
Price to Book Ratio 6.81
Return on Assets (%) 1.77
Return on Capital (%) 3.34
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 34.40
Total Assets 2594.04
Total Liabilities 2594.04
Total Equity 1417.25
Share Outstanding 119305676
Price to Book Ratio 10.83
Return on Assets (%) 3.69
Return on Capital (%) 6.14
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 118.59
Total Assets 1565.64
Total Liabilities 1565.64
Total Equity 731.10
Share Outstanding 458409
Price to Book Ratio 0.00
Return on Assets (%) 4.07
Return on Capital (%) 7.37
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 140.69
Total Assets 1348.69
Total Liabilities 1348.69
Total Equity 529.10
Share Outstanding 215000
Price to Book Ratio 0.00
Return on Assets (%) 0.16
Return on Capital (%) 0.34
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 62.42
Total Assets 1312.22
Total Liabilities 1312.22
Total Equity 1172.63
Share Outstanding 119536952
Price to Book Ratio 7.03
Return on Assets (%) 0.73
Return on Capital (%) 0.82
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 90.16
Total Assets 1271.94
Total Liabilities 1271.94
Total Equity 1141.27
Share Outstanding 119305676
Price to Book Ratio 6.81
Return on Assets (%) 0.43
Return on Capital (%) 0.49
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 7.43
Total Assets 1187.45
Total Liabilities 1187.45
Total Equity 1112.78
Share Outstanding 119305676
Price to Book Ratio 10.83
Return on Assets (%) 0.46
Return on Capital (%) 0.5
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 86.67
Total Assets 548.42
Total Liabilities 548.42
Total Equity 517.48
Share Outstanding 458409
Price to Book Ratio 0.00
Return on Assets (%) -1.56
Return on Capital (%) -1.66
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 10.74
Total Assets 396.46
Total Liabilities 396.46
Total Equity 391.66
Share Outstanding 215000
Price to Book Ratio 0.00
Return on Assets (%) -7.58
Return on Capital (%) -7.68
Particulars MAR 2024 (Values in Cr)
Net Income 73.44
Cash from Operations 172.96
Cash from Investing -82.79
Cash from Financing -198.10
Net change in Cash -137.16
Free Cash Flow 257.35
Particulars MAR 2023 (Values in Cr)
Net Income 47.16
Cash from Operations 104.34
Cash from Investing 429.44
Cash from Financing -170.24
Net change in Cash 349.60
Free Cash Flow 273.34
Particulars MAR 2022 (Values in Cr)
Net Income 117.94
Cash from Operations 203.45
Cash from Investing -703.12
Cash from Financing 440.42
Net change in Cash -92.80
Free Cash Flow 321.17
Particulars MAR 2021 (Values in Cr)
Net Income 95.09
Cash from Operations 31.60
Cash from Investing -34.54
Cash from Financing -5.62
Net change in Cash -37.28
Free Cash Flow 85.86
Particulars MAR 2020 (Values in Cr)
Net Income 29.35
Cash from Operations 8.27
Cash from Investing -27.55
Cash from Financing 89.82
Net change in Cash 55.68
Free Cash Flow 38.48
Particulars MAR 2024 (Values in Cr)
Net Income 7.04
Cash from Operations 9.99
Cash from Investing -24.42
Cash from Financing -5.94
Net change in Cash -22.70
Free Cash Flow 22.38
Particulars MAR 2023 (Values in Cr)
Net Income 7.58
Cash from Operations 13.21
Cash from Investing 31.71
Cash from Financing -8.35
Net change in Cash 34.76
Free Cash Flow 74.95
Particulars MAR 2022 (Values in Cr)
Net Income 5.57
Cash from Operations -16.36
Cash from Investing -635.99
Cash from Financing 568.62
Net change in Cash -85.74
Free Cash Flow 24.26
Particulars MAR 2021 (Values in Cr)
Net Income -8.56
Cash from Operations -6.51
Cash from Investing -14.76
Cash from Financing 96.94
Net change in Cash 75.93
Free Cash Flow 5.96
Particulars MAR 2020 (Values in Cr)
Net Income -29.57
Cash from Operations -0.90
Cash from Investing -193.65
Cash from Financing 203.98
Net change in Cash 10.21
Free Cash Flow -0.81
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 5173.40 118.90 33.67 183907.88 4197.50 / 8345.85
WARREN TEA LTD. 45.12 161.14 0.57 53.92 39.70 / 86.00
MULLER & PHIPPS (INDIA) LTD. 247.50 0.00 -10.38 15.47 192.00 / 726.20
FUTURE ENTERPRISES LTD 0.57 0.00 -0.09 42.86 0.56 / 0.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
TRENT LTD 5173.40 124.66 36.08 183907.88 4197.50 / 8345.85
Saptak Chem And Business Limit 3.34 0.00 -1.64 3.58 2.40 / 4.80
WARREN TEA LTD. 45.12 0.00 0.62 53.92 39.70 / 86.00
MULLER & PHIPPS (INDIA) LTD. 247.50 0.00 -10.38 15.47 192.00 / 726.20

MEDPLUS HEALTH SERV LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
806.15 -1.73 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 809.40
  • 26 Days 777.30
  • 10 Days 802.00
  • 50 Days 764.20
  • 12 Days 798.20
  • 100 Days 755.40
  • 20 Days 784.50
  • 200 Days 744.50
823.67 PIVOT

First Support

808.58

First Resistance

835.43

Second Support

796.82

Second Resistance

850.52

Third Support

781.73

Third Resistance

862.28

RSI

58.54

ADX

33.13

MACD

20.94

Williams % R

-24.89

Commodity Channel Index (CCI)

53.35

Date

2025-04-30

Week

68773.00

Same Day

90614.00

Month

75857.00

1 Year

0.42

3 Year

0.51

Over 1 Month

7.40%

down

Over 1 Year

15.67%

down

Over 3 Months

10.06%

down

Over 3 Years

-6.18%

down

Over 6 Months

26.20%

down

Over 5 Years

0.00%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MEDPLUS HEALTH SERV LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
17.86%
Promoter Holdings
40.33%
FII
15.6%
DII
26.19%
Promoter Shares(Pledge Percentage)
59.34%
Name Shares Category
Lone Furrow Investments Private Limited 1.7280732E7 (14.44%) Shareholding of Promoter and Promoter Group
Agilemed Investments Pvt Ltd 1.5649495E7 (13.07%) Shareholding of Promoter and Promoter Group
Madhukar Reddy Gangadi 1.53504E7 (12.82%) Shareholding of Promoter and Promoter Group
Nippon Life India Trustee Ltd-a/c Nippon India Mul 9070114.0 (7.58%) Public Shareholding
Kotak Small Cap Fund 4164186.0 (3.48%) Public Shareholding
Franklin India Flexi Cap Fund 3684109.0 (3.08%) Public Shareholding
Invesco India Midcap Fund 3299215.0 (2.76%) Public Shareholding
Arisaig Asia Fund Limited 2753465.0 (2.3%) Public Shareholding
Icici Prudential Pharma Healthcare And Diaganostic 1824986.0 (1.52%) Public Shareholding
Pravesa Holding Private Limited 1810330.0 (1.51%) Public Shareholding
Sbi Long Term Equity Fund 1723010.0 (1.44%) Public Shareholding
Hdfc Life Insurance Company Limited 1511628.0 (1.26%) Public Shareholding
Kuwait Investment Authority Fund 227 1452388.0 (1.21%) Public Shareholding
Goldman Sachs Funds - Goldman Sachs India Equity P 1413291.0 (1.18%) Public Shareholding
Mercer Qif Fund Plc-mercer Investment Fund 1 1242737.0 (1.04%) Public Shareholding

News

Left Arrow
Right Arrow

MEDPLUS HEALTH SERV LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MEDPLUS HEALTH SERV LTD Share Price

MedPlus Health Services Limited was incorporated as a Private Limited Company with the name 'MedPlus Health Services Private Limited' at Hyderabad on 30 November, 2006. The Company converted from a Private Limited Company to a Public Limited Company, pursuant to a Special Resolution passed by Shareholders at the Extra Ordinary General Meeting held on 01 June 2021 and name of the Company was changed to MedPlus Health Services Limited on 28 June 2021. The Company is engaged in providing pathological laboratory testing and manufacturing, trading and contract manufacturing of pharma, FMCG and beauty products and rendering of management services to group companies and holds investments in subsidiary companies. The Company has six direct subsidiaries and five step-down subsidiaries.

MedPlus is the second largest pharmacy retailer in India in terms of revenue and number of stores as of 31 March 2021.The company offer a wide range of products, including (i) pharmaceutical and wellness products, including medicines, vitamins, medical devices and test kits, and (ii) fast-moving consumer goods, such as home and personal care products, including toiletries, baby care products, soaps and detergents, and sanitizers.The company grown from operating initial 48 stores in Hyderabad at the conception of the business to operating India's second largest pharmacy retail network of over 2,000 stores distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal and Maharashtra, as of 31 March 2021.The number of stores has grown since the conception of the business and, as of 30 June 2021, MedPlus operated 520 stores in Karnataka, 458 stores in Tamil Nadu, 443 stores in Telangana, 274 stores in Andhra Pradesh, 201 stores in West Bengal, 186 stores in Maharashtra and 83 stores in Odisha.

On 21 January 2021, the Company has issued and allotted 254674 equity shares of Rs 10 each as bonus shares to the shareholders in the ratio of 1.25:1.

On 05 August 2021,the company has allotted 29910085 equity shares of Rs 2 each on conversion of preference shares.The allotment of 14,976,000 Equity Shares to Gangadi Madhukar Reddy upon conversion of 2,995,200 Series B CCPS held by it,6,660,575 Equity Shares to Agilemed Investments Private Limited upon conversion of 1,332,115 Series B1 CCPS held by it and 8,273,510 Equity Shares to Lone Furrow Investments Private Limited upon conversion of 1,654,702 Series B2 CCPS.

During the month of December 2021,the company cameout with an Rs 1398.30-crore public issue which comprised a fresh issue of Rs 600 crore and an offer for sale(OFS) of Rs 798.30 crore by selling shareholders.The IPO shares were allotted at the price of Rs 796 per share including a premium of Rs 794 per share.The net proceeds of the fresh issue will be utilised for funding working capital requirement of subsidiary,Optival and general corporate purposes.The allotted shares were listed on the BSE Ltd and National Stock Exchange of India Ltd(NSE) on 23 December 2021.

During the year 2021-22, 747 stores were increased to the cluster store network of the Group. In March 2022, the Company launched its first Diagnostic Centre in Gachibowli, Hyderabad. It marked the presence with 2,748 Physical Stores during the year 2022.

During the year 2022-23, 1144 stores were added to the cluster store network of the Company. As on March 31, 2023 the Company's total fleet of stores stood at 3822. The Company launched its Diagnostic Services Centre in the year 2021 as pilot project.

During the year 2022-23, the Company incorporated a Subsidiary Company namely MedPlus Insurance Brokers Private Limited.

Parent organization Indian Private
NSE symbol MEDPLUS
Founded 2006
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Medplus Health Services Ltd?

Answer Field

The share price of Medplus Health Services Ltd for NSE is ₹ 806.15 and for BSE is ₹ 788.95.

What is the Market Cap of Medplus Health Services Ltd?

Answer Field

The market cap of Medplus Health Services Ltd for NSE is ₹ 96,36.47 Cr. and for BSE is ₹ 94,30.86 Cr. as of now.

What is the 52 Week High and Low of Medplus Health Services Ltd?

Answer Field

The 52 Week High and Low of Medplus Health Services Ltd for NSE is ₹ 875.65 and ₹ 616.00 and for BSE is ₹ 876.75 and ₹ 603.00.

How to Buy Medplus Health Services Ltd share?

Answer Field

You can trade in Medplus Health Services Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Medplus Health Services Ltd?

Answer Field

The 1 year returns on the stock has been 15.67%.

What is the Current Share Price of Medplus Health Services Ltd?

Answer Field

Medplus Health Services Ltd share price is for NSE ₹ 806.15 & for BSE ₹ 788.95 as on Apr 30 2025 03:30 PM.

What is the Market Cap of Medplus Health Services Ltd Share?

Answer Field

The market cap of Medplus Health Services Ltd for NSE ₹ 96,36.47 & for BSE ₹ 94,30.86 as on Apr 30 2025 03:30 PM.

What is the P/E Ratio of Medplus Health Services Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM the price-to-earnings (PE) ratio for Medplus Health Services Ltd share is 264.39.

What is the PB ratio of Medplus Health Services Ltd Share?

Answer Field

As on Apr 30 2025 03:30 PM, the price-to-book (PB) ratio for Medplus Health Services Ltd share is 101.08.

How to Buy Medplus Health Services Ltd Share?

Answer Field

You can trade in Medplus Health Services Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Medplus Health Services Ltd Share on Bajaj Broking App?

Answer Field

To buy Medplus Health Services Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Medplus Health Services Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|